We could hypothesize that 120 min after radiopharmaceutical injection as acquisition time for 18F-PSMA-1007 PET could be a good balance between optimal PCa lesion contrast and optimal patient throughput in clinical practice, but this hypothesis needs to be verified through high-quality studies [26]. Here, FOLH1 is linked to posterior cortical atrophy.